KMT2D and goblet cell carcinoma: Most of these mutations were also identified in other studies; for example, mutations in KDM6A, KMT2D, SMARCA4, and ARID1A have been previously reported not only in appendiceal adenocarcinomas but also in appendiceal goblet cell carcinomas [31,32].